|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
32251842 |
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital.
OBJECTIVES: Describe the clinical characteristics of patients in Fangcang Ho |
1.8 KB |
2020-04-08 |
|
12 |
|
35 |
2021-01-13
|
| PubMed |
32251790 |
Severe Acute Respiratory Syndrome (SARS) and Coronavirus disease-2019 (COVID-19): From Causes to Preventions in Hong Kong.
Hong Kong has been recently attacked by the coronavirus disease-2019 (COVID-1 |
685 Bytes |
2020-04-08 |
|
12 |
|
8 |
2021-01-13
|
| PubMed |
32251668 |
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis.
BACKGROUND & AIMS: Infection with SARS-CoV-2 |
2.54 KB |
2020-04-08 |
|
13 |
|
24 |
2021-01-13
|
| PubMed |
32250385 |
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Importance: In December 2019, a novel coronavirus (severe acute respirat |
3.56 KB |
2020-04-08 |
|
33 |
|
66 |
2021-01-13
|
| PubMed |
32247898 |
Unknown unknowns - COVID-19 and potential global mortality.
COVID-19 (SARS-CoV-2) is currently a global pandemic. This paper will attempt to estimate global infection rates and potential resultant mor |
1.2 KB |
2020-04-08 |
|
12 |
|
15 |
2021-01-13
|
| PubMed |
32247326 |
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study.
BACKGROUND: The coronavirus disease 2019 (COVID-19) epidem |
2.86 KB |
2020-04-08 |
|
12 |
|
5 |
2021-01-13
|
| PubMed |
32246886 |
COVID-19 transmission through asymptomatic carriers is a challenge to containment.
Since the first report on the outbreak of a novel coronavirus disease COVID-19 in Wuhan, Hubei, China, in December, 2 |
1008 Bytes |
2020-04-08 |
|
12 |
|
8 |
2021-01-13
|
| PubMed |
32246317 |
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.
Severe coronavirus disease 2019 (COVID-19) is commonly complicated with coagulopathy, the difference |
1.32 KB |
2020-04-08 |
|
15 |
|
10 |
2021-01-13
|
| PubMed |
32245844 |
On being a neurologist in Italy at the time of the COVID-19 outbreak.
Italy is facing its fifth week of crisis due to the COVID-19 outbreak, with affected patients and deaths near to 70.000 and 6000 r |
1.01 KB |
2020-04-08 |
|
32 |
|
6 |
2021-01-13
|
| PubMed |
32243945 |
Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible |
682 Bytes |
2020-04-08 |
|
12 |
|
8 |
2021-01-13
|
